Clinical Trials Directory

Trials / Completed

CompletedNCT02472405

Multiplex Laser vs. PDL (Pulsed Dye Laser ) in the Treatment of Surgical Scars

Comparing the 595/1064nm Multiplex Laser to the 595nm PDL in the Treatment of Surgical Scars in a Blinded, Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study aims to determine if the 595nm Pulsed dye laser, the combined 595/1064nm Multiplex laser or no treatment results in a better outcome in the quality of the surgical scar using the multiplex cynergy laser, starting treatment the day of suture removal.

Detailed description

This study aims to determine if the 595nm Pulsed dye laser, the combined 595/1064nm Multiplex laser or no treatment results in a better outcome in the quality of the surgical scar using the multiplex cynergy laser, starting treatment the day of suture removal. Patients will be offered the opportunity of enrolling in the trial before their surgery. If they qualify and agree to participate they will sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) form. The surgical defect should be closed primarily, with the minimal scar length being 3cm. The scar will be randomized into 3 equal thirds, each third will randomly receive either: no treatment, 595nm PDL, or 595/1064nm Multiplex laser. A total of 3 laser treatments will be performed over a period of 3 weeks (one treatment session performed every week), and the patient will come in for a final follow up visit, for a final assessment of the scar using the Patient and Observer Scar Assessment Scale (POSAS) system.

Conditions

Interventions

TypeNameDescription
DEVICE595/1064nm Multiplex LaserThe multiplex cynergy laser will be used for this study. A third of the scar will solely be treated with the 595nm PDL.
DEVICE595nm PDLOne third of the scar will be treated with 595nm PDL solely for 3 weeks (1 treatment session per week).

Timeline

Start date
2015-01-01
Primary completion
2016-11-01
Completion
2017-11-01
First posted
2015-06-15
Last updated
2018-08-21
Results posted
2018-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02472405. Inclusion in this directory is not an endorsement.